Stellus Capital repurchased 274K shares at $8.88 in Q2 2026
BDC executed $2.4M in equity repurchases; $17.6M remains under $20M authorization through March 2027
What the filing says
Stellus Capital Investment Corporation (NYSE:SCM) repurchased 274,343 shares of common stock during the second quarter of 2026 at a weighted average price of $8.88 per share, totaling approximately $2.4 million in aggregate investment. The repurchases were executed pursuant to the Company's Board-approved share repurchase program.
As of June 30, 2026, approximately $17.6 million remained available for repurchases under the authorized $20.0 million program. The Company expects the repurchase program to remain in effect until the earlier of March 2, 2027 or the full repurchase of $20.0 million of outstanding common stock.
Management noted in its preliminary results release that the accretive impact of equity repurchases contributed to the estimated NAV per share increase of $0.22 to $0.30, or 1.8% to 2.4%, during the quarter. The Company is a closed-end, externally-managed business development company investing primarily in private middle-market companies through debt and equity financing.
Pursuant to the Company's share repurchase program approved by its Board of Directors, during the second quarter of 2026, the Company repurchased 274,343 shares of its common stock at a weighted average price of $8.88 per share, representing an aggregate investment of approximately $2.4 million. — Stellus Capital Investment Corp 8-K filing · View on SEC EDGAR →
What this means
Stellus Capital, a business development company, executed $2.4 million in equity repurchases during Q2 2026, reducing share count and contributing to NAV accretion. The filing indicates the $20 million authorization remains active through March 2, 2027 or until fully deployed, with $17.6 million still available. For a BDC with a portfolio of approximately $965–975 million at fair value, share buybacks represent a modest but deliberate capital allocation decision; the filing attributes part of the quarter's NAV-per-share growth directly to the accretive effect of repurchases. This execution is routine activity under an existing Board-approved program, not a new authorization.
Frequently asked questions
- What is the timeline for Stellus Capital's repurchase program?
- The program remains in effect until the earlier of March 2, 2027 or the full repurchase of $20.0 million of common stock. As of June 30, 2026, $17.6 million remained available, indicating the program had deployed $2.4 million through Q2 2026.
- Why did Stellus repurchase shares at $8.88 per share in Q2 2026?
- The filing does not specify the rationale beyond Board approval of the program. The company does note that the repurchases had an accretive impact on NAV per share, contributing to the estimated NAV increase of 1.8% to 2.4% during the quarter.
- How do repurchases affect a BDC's NAV per share?
- When a BDC repurchases shares below NAV, it can accrete NAV per share because the remaining shares benefit from the same dollar amount of net assets spread across fewer shares. Stellus noted that repurchases partially offset the dilution from dividends exceeding net investment income.
- What is the status of Stellus Capital's share repurchase authorization?
- The $20.0 million authorization is an existing Board-approved program. This filing reports Q2 2026 execution activity; no new authorization was announced in this press release.
- Is this repurchase program typical for business development companies?
- Yes, BDCs often implement share repurchase programs to manage capital, support NAV, and provide flexibility in capital allocation. Stellus's program is structured with a dollar cap ($20 million) and an expiration date, which are standard features for such initiatives.